- Q1 2024 IMCD NV Earnings Call TranscriptApr 26, 2024€141.7 (-4.90%)Earnings
- Q3 2023 IMCD NV Earnings Call TranscriptNov 10, 2023€126.8 (-0.39%)Earnings
- Q2 2023 IMCD NV Earnings Call TranscriptAug 04, 2023€128.15 (-1.42%)Earnings
- Q1 2023 IMCD NV Earnings Call TranscriptApr 26, 2023€137.9 (-3.97%)Earnings
- Q4 2022 IMCD NV Earnings Call TranscriptFeb 24, 2023€143.4 (-2.45%)Earnings
- Q3 2022 IMCD NV Earnings Call TranscriptNov 10, 2022€141.5 (+6.31%)Earnings
- Q2 2022 IMCD NV Earnings Call TranscriptAug 04, 2022€152.8 (+0.20%)Earnings
- Q1 2022 IMCD NV Earnings Call TranscriptApr 29, 2022€152.7 (-1.13%)Earnings
- Q4 2021 IMCD NV Earnings Call TranscriptFeb 25, 2022€141.35 (+0.60%)Earnings
- Q3 2021 IMCD NV Earnings Call TranscriptNov 09, 2021€197.05 (+0.38%)Earnings
- Q2 2021 IMCD NV Earnings Call TranscriptAug 04, 2021€163.15 (+10.46%)Earnings
- Q1 2021 IMCD NV Earnings Call TranscriptApr 29, 2021€120.6 (-1.19%)Earnings
- Full Year 2020 IMCD NV Earnings Call TranscriptFeb 26, 2021€101.95 (-1.35%)Earnings
- Nine Months 2020 IMCD NV Earnings Call TranscriptNov 11, 2020€105.35 (+2.13%)Earnings
- IMCD N.V., Signet Excipients Private Limited - M&A Call TranscriptSep 15, 2020
- Half Year 2020 IMCD NV Earnings Call TranscriptAug 18, 2020€90.68 (-0.31%)Earnings
- Q1 2020 IMCD NV Trading Update Call TranscriptApr 20, 2020
- Full Year 2019 IMCD NV Earnings Call TranscriptFeb 27, 2020€76.6 (+1.26%)Earnings
- Nine Months 2019 IMCD NV Earnings Call TranscriptNov 12, 2019€72.9 (+1.32%)Earnings
- Half Year 2019 IMCD NV Earnings Call TranscriptAug 16, 2019€62 (-15.13%)Earnings
- Q1 2019 IMCD NV Earnings Call TranscriptMay 08, 2019€71.7 (+2.94%)Earnings
- Full Year 2018 IMCD NV Earnings Call TranscriptMar 01, 2019€69Earnings
Q1 2022 IMCD NV Earnings Call Transcript
Hello, and welcome to the IMCD N.V. Q1 2022 Results Call. My name is Courtney, and I'll be your coordinator for today's event. Please note that this call is being recorded. (Operator Instructions)
And I will now hand you over to your host, Piet van der Slikke, CEO, to begin today's conference. Thank you.
Thank you, Courtney, and welcome, everybody. I'm here with my colleague Hans Kooijmans, traditionally, and we will be pleased in a minute to answer your questions. You will have seen that the first quarter results were very strong with EBITDA growth of 59% to almost EUR 140 million. Most of the growth was organic and based on strong demand, increasing prices and ability to strengthen our margins and expansion of our business with new product lines.
All regions and business segments contributed to the growth. Supply chains and lead times remain challenging. Also in this quarter, we have been able to execute our strategy by doing acquisitions to complement business
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)